Last 12 months
Inside the activity.
1 purchase rows · 44 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC |
Boughton SoleilChief Legal Officer
|
Tax withholdingClass A Common Stock | 5,255 | $6.35 | $33,369.25 |
DisclosureSEC source: 0001773751-21-000087 · wf-form4_163979444378576.xml · nonDerivative · entry 2 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,715 F2 · kind: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC |
Boughton SoleilChief Legal Officer
|
Exercise / conversionClass A Common Stock | 10,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-21-000087 · wf-form4_163979444378576.xml · nonDerivative · entry 1 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 13 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124 Underlying: Class A Common Stock · 164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F7 · derivative.exercise_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. F7 · derivative.expiration_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 12 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,715 Underlying: Class A Common Stock · 1,670 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 11 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,882 Underlying: Class A Common Stock · 1,221 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 10 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127 Underlying: Class A Common Stock · 10 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 324 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 9 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 Underlying: Class A Common Stock · 324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 8 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198 Underlying: Class A Common Stock · 22 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 7 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,970 Underlying: Class A Common Stock · 1,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 6 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110 Underlying: Class A Common Stock · 14 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 5 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 Underlying: Class A Common Stock · 692 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 4 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58 Underlying: Class A Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · derivative · entry 3 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,908 Underlying: Class A Common Stock · 415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Tax withholdingClass A Common Stock | 1,368 | $6.35 | $8,686.80 |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · nonDerivative · entry 2 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,857 F2 · kind: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:26 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionClass A Common Stock | 5,648 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-21-000083 · wf-form4_163979438282291.xml · nonDerivative · entry 1 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:23 UTC |
Abraham Jack10% owner
|
SaleClass A Common Stock | 1,000,000 | $5.55 | $5,548,300.00 |
DisclosureSEC source: 0001062993-21-013067 · form4.xml · nonDerivative · entry 1 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,171,203 F1 · security: The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. F2 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 13:39 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
PurchaseClass A Common Stock | 81,100 | $5.93 | $480,712.14 |
DisclosureSEC source: 0001773751-21-000075 · wf-form4_163957555105310.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 81,100 F1 · price: Price reported constitutes the average weighted price of shares purchased. Shares were purchased at varying prices in the range of $5.79 - $6.22. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 18:04 UTC |
Bhattacharyya AmbarDirector
|
OtherClass A Common Stock | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-046609 · doc4.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,412 F1 · kind: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. F1 · price: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. F1 · balance_after: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 18:07 UTC |
Maltz Jules A.Director · 10% owner
|
OtherClass A Common Stock | 9,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-046611 · doc4.xml · nonDerivative · entry 1 Maltz Jules A. · CIK 0001553254 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,207 F1 · kind: Represents a pro rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). F1 · price: Represents a pro rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 02:03 UTC |
Becklund IreneInterim PFO/PAO
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000071 · wf-form4_163728739407240.xml · derivative · entry 1 Becklund Irene · CIK 0001894602 · Interim PFO/PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. 25% of the RSUs will vest on each of December 15, 2021, March 15, 2022, June 15, 2022, and September 15, 2022, subject to the reporting Person's continuous service with the issuer through each vesting date. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. 25% of the RSUs will vest on each of December 15, 2021, March 15, 2022, June 15, 2022, and September 15, 2022, subject to the reporting Person's continuous service with the issuer through each vesting date. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. 25% of the RSUs will vest on each of December 15, 2021, March 15, 2022, June 15, 2022, and September 15, 2022, subject to the reporting Person's continuous service with the issuer through each vesting date. Read SEC document |
| September 22, 2021 Filed Dec 14, 2021 21:44 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
GiftClass A Common Stock | 2,874,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000073 · wf-form4_163951827454035.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 Disclosed balance after: 2,874,769 F1 · shares: These shares represent a gift to the Dudum Family Heritage Trust UAD 8-10-2021 from the Andrew Dudum 2015 Trust dated July 2, 2015. Read SEC document |
| September 22, 2021 Filed Dec 14, 2021 21:44 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
GiftClass A Common Stock | 2,874,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000073 · wf-form4_163951827454035.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 5,357,635 F1 · shares: These shares represent a gift to the Dudum Family Heritage Trust UAD 8-10-2021 from the Andrew Dudum 2015 Trust dated July 2, 2015. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 13 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,361 Underlying: Class A Common Stock · 811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F7 · derivative.exercise_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. F7 · derivative.expiration_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,296 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,133 Underlying: Class A Common Stock · 8,296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,103 Underlying: Class A Common Stock · 1,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 679 Underlying: Class A Common Stock · 48 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,759 Underlying: Class A Common Stock · 1,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 948 Underlying: Class A Common Stock · 95 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,763 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,631 Underlying: Class A Common Stock · 4,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 Underlying: Class A Common Stock · 14 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after December 15, 2019, subject to Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after December 15, 2019, subject to Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 693 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,231 Underlying: Class A Common Stock · 693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after December 15, 2019, subject to Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after December 15, 2019, subject to Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 131 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266 Underlying: Class A Common Stock · 131 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2018. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2018. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,643 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,289 Underlying: Class A Common Stock · 6,643 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2018. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2018. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Tax withholdingClass A Common Stock | 9,572 | $8.66 | $82,893.52 |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,911 F2 · kind: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:05 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 24,342 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-036408 · doc4.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 13 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Class A Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F7 · derivative.exercise_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. F7 · derivative.expiration_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,670 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 12 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,385 Underlying: Class A Common Stock · 1,670 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 11 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,103 Underlying: Class A Common Stock · 1,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 10 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137 Underlying: Class A Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 324 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 9 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,536 Underlying: Class A Common Stock · 324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 8 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220 Underlying: Class A Common Stock · 22 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 7 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,078 Underlying: Class A Common Stock · 1,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 6 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 Underlying: Class A Common Stock · 14 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 693 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 5 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,231 Underlying: Class A Common Stock · 693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 4 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66 Underlying: Class A Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 416 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · derivative · entry 3 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,323 Underlying: Class A Common Stock · 416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Tax withholdingClass A Common Stock | 1,369 | $8.66 | $11,855.54 |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · nonDerivative · entry 2 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,577 F2 · kind: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Carroll Patrick HarrisonChief Medical Officer
|
Exercise / conversionClass A Common Stock | 5,650 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-036478 · doc4.xml · nonDerivative · entry 1 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Cosgrove Delos M.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036480 · doc4.xml · derivative · entry 3 Cosgrove Delos M. · CIK 0001824222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99 Underlying: Class A Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 occurring on or after December 15, 2019, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 occurring on or after December 15, 2019, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:06 UTC |
Cosgrove Delos M.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 554 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036480 · doc4.xml · derivative · entry 2 Cosgrove Delos M. · CIK 0001824222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,985 Underlying: Class A Common Stock · 554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on September 15, 2021. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 occurring on or after December 15, 2019, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 occurring on or after December 15, 2019, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.